Latin Manharlal Securities Pvt Ltd. 124 Viraj, S,V.Road, Khar (W), Mumbai S t o c k I d e a

Size: px
Start display at page:

Download "Latin Manharlal Securities Pvt Ltd. 124 Viraj, S,V.Road, Khar (W), Mumbai S t o c k I d e a"

Transcription

1 S t o c k I d e a Date: 28-May -12 CMP: ` TARGET: `220.0 Upside: 38% B U Y SENSEX NIFTY 4920 Eq. Cap. (` Crs) Face Value (`) 10.0 M. Cap (` Crs) `385 BSE Code Latin Manharlal Securities Pvt Ltd. 124 Viraj, S,V.Road, Khar (W), Mumbai TALWALKARS BETTER VALUE FITNESS LTD. (TBVFL) Incorporated in 2003, Talwalkars Better Value Fitness Ltd (TBVFL) is the largest fitness chains in India offering a diverse suite of services including gyms, spas, aerobics and health counseling under the brand Talwalkars. It has pioneered the concept of gyms in India and today is a recognized name in the health and fitness industry. The company has grown rapidly since its inception and as on date operates 128 health clubs in 68 cities belonging to 18 states of the country serving over 1,25,000 members. Pan India presence: Holds highest market share in the Organised health club market TBVFL has pan India presence and holds highest market share in the organised health club market in India (~ 10%). In a fragmented health and fitness industry, where the demand for quality services is high while the supply is largely unorganized (primarily from singly city operators) and nonstandardized, TBVFL has an edge over its peers. NSE Code TALWALKARS Zero Capex model of HI FI gyms: results in accelerated expansion Financial Year Apr-Mar 52-w H/L 267/108 Avg. Daily Vol. 14,359 TTM EPS (`) 9.15 TTM P/E (x) 17.4x BVPS (`) 58.9 P/BVPS (x) 2.7x Stock vs. Sensex The newly launched HIFI format has accelerated TBVFL penetration into the smaller markets. With a small sized format, HI FI health club can be rolled out in 8-10 weeks against weeks for a typical Talwalkars health club. For FY13E, management has guided for ~25-30 additional gym roll out (including owned gyms/subsidiaries, franchises and JVs) taking the total number of gyms to ~160. Focus on Franchisee/subsidiary model to improve return ratios TBFVL is now focusing on adding more franchisees and also adopting a JVs/subsidiary model which we believe will result in lower capex (due to 51% holdings in subsidiary health club) and improve return ratios (as TBVFL receives a royalty of 6% of revenues for 1st 3 yrs which is 8% thereafter). Broaden its scope from being a gym player to a fitness player: Nu Form Gym Studios TBVFL has broadened its scope from being a gym player to a fitness player by introducing Nu Form Gym studios (high product EBITDA) with a focus on weight loss using the EMS (Electric Muscle Stimulation) method. Nu Form is priced at a significantly higher premium for people who are more conscious of weight loss than only of health and fitness in gyming. Currently 6 Nu Form Studios are operational in Mumbai. Nu Form studios opened in April 2012 received a great response with ~140 members in less than one month of its inauguration. Consistent financial performance Number of Health Clubs has increased at a CAGR of 28% over FY07-FY13E. Number of Members has increased at a CAGR of 29% over FY07-FY13E. Achieved 4 year CAGR (FY 08-12) of 30% in Revenues, 35% in EBITDA & 44% in PAT. The company continues to maintain debt equity of ~ 1:1. The company has properties which has current market values considerably higher than the book value. At the CMP of `159.50, the stock is trading at 10.9x its FY14E EPS of ` We recommend BUY on the stock with a months target price of `220, providing an upside of 38% from the current levels. Please Refer DISCLAIMER on the Last Page

2 Company Profile Promoters have over 5 decades of experience in managing Gym Talwalkars Better Value Fitness Ltd (TBVFL) is the largest fitness chains in India offering a diverse suite of services including gyms, spas, aerobics and health counseling under the brand Talwalkars. It has pioneered the concept of gyms in India and today is a recognized name in the health and fitness industry. TBVFL is 2 nd largest health club chain in Asia and is present in top 20 chains in world in the owned health clubs category. TBVFL was formed in 2003 but its co-promoters i.e. the Talwalkars has been in the fitness business for over five decades (opened its first gym in 1962 in Mumbai). Business Model The company has grown rapidly since its inception and as on date operates 128 health clubs in 68 cities belonging to 18 states of the country serving over 1,25,000 members. Out of the total number of health clubs, 90 are owned by TBVFL, 10 are legacy gyms, 13 are operated through 51:49 JVs (6 are with Pantaloons Retails), 7 are purely franchisee of Talwalkars outlets and 8 are operating under the HI FI brand targeting the Tier II and III cities. Source: Company, LMSPL Research Considering the strong business model and expansion plans coupled with increasing awareness of health and fitness, TBVFL is well poised to deliver high growth rate in the coming years. INVESTMENT POSITIVES Betting on Health Conscious Young Indian Population Indian fitness industry is a hugely underpenetrated market compared to several developed and developing countries in the world. For instance, 16.0% of the U.S population have fitness club membership compared to a mere 0.4% for Indian markets (taken for Top 7 cities). This is despite the fact that India has the highest incidence of diabetes people in the world pegged at 50.8 million people. Talwalkars Better Value Fitness Ltd May-2012

3 According to industry body FICCI, the penetration level of fitness club membership is <5% of the urban population in India. Although the industry is highly fragmented and dominated by mom and pop gyms, the large players have an edge in terms of product differentiation and service offerings. We believe a significant rise in lifestyle related diseases on account of eating habits of junk foods (Pizza, Burgers, Pasta) and growing awareness of being fit and attractive will be the main growth driver for this industry and TBVFL is better placed to capture this demand. Company has its own 25,000 sq ft residential training academy in Thane. Strength = Consistency + Quality + Trained Manpower Across all locations the health club experience of TBVFL remains uniform with similar equipments and Infrastructure. Thus brand identity ensures quality in both health club experience and member numbers. The TBVFL health clubs are well equipped with world class equipments from reputed international manufacturer, viz., Precor, Matrix, Hoist etc. Moreover its in-house training ensures quality of the Trainers and improves the resource pool for rapid expansion. The company has its own 25,000 sq ft residential training academy in Thane, Mumbai which gives training (~30 days) to existing and newly recruited trainers. Pan India presence: Holds highest market share in the Organised health club market TBVFL has pan India presence and holds highest market share in the organised health club market in India (~ 10%). In a fragmented health and fitness industry, where the demand for quality services is high while the supply is largely unorganized (primarily from singly city operators) and non-standardized, TBVFL has an edge over its peers. The reason could be the followings: TBVFL holds highest market share in the organised health club market in India (~ 10%). Most of the Organized Health club chains have presence limited to only Metros and Tier I cities unlike TBVFL which has customers spread over Tier I,II,III Cities through different formats and price points. Zonal Distribution Tier City distribution 26% 6% East West 25% 32% Tier I 41% North South Tier II Tier III 27% 43% TBVFL has demonstrated the scalability of its health clubs by establishing presence in smaller towns of India like Anand, Gandhinagar, Ichalkaranji, Ranchi, Jamshedpur, etc and the response has been good so far. The company continues to bring quality fitness at affordable prices across the country. Talwalkars Better Value Fitness Ltd May-2012

4 Zero Capex model of HI FI gyms: results in accelerated expansion Business Strategy: HI FI model The newly launched HIFI format has accelerated TBVFL penetration into the smaller markets. HIFI format mainly targeted towards the middle income population in the smaller towns and cities (tier III and IV cities where population is about 5 lakh) across India to avail of high quality gyms at reasonable prices. HIFI is different from Talwalkars format on 3 grounds: (i) set up cost (between Rs. 75 lakh - Rs. 95 lakh as against the existing model of Rs Crs - Rs. 2 Crs), (ii) floor area size (range of sq. ft. compared to regular one of sq.ft) and (iii) membership fees structure (range of Rs Rs compared to regular one of Rs Rs ). Rent for Hi Fi will be considerably low, which will be around 3% to 4% of revenue compared to regular one which is around 10% to 12% of revenue. Source: Company, LMSPL Research No of Health Clubs - TBVFL No of Members (In '000) For FY13E, management has guided for ~25-30 additional gym roll out FY07 FY08 FY09 FY10 FY11 FY12 FY13(YTD) At the Beginning Additions Source: Company, LMSPL Research 20 0 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12# With a small sized format, HI FI health club can be rolled out in 8-10 weeks against weeks for a typical Talwalkars health club. For FY13E, management has guided for ~25-30 additional gym roll out (including owned gyms/subsidiaries, franchises and JVs) taking the total number of gyms to ~160. Focus on Franchisee/subsidiary model to improve return ratios TBFVL is now focusing on adding more franchisees and also adopting a JVs/subsidiary model which we believe will result in lower capex (due to 51% holdings in subsidiary health club) and improve return ratios (as TBVFL receives a royalty of 6% of revenues for 1 st 3 yrs which is 8% thereafter). Source: Company Talwalkars Better Value Fitness Ltd May-2012

5 Franchise model get full support from TBVFL with regards to the set-up of gym, equipment, trainers etc. The company offers a turnkey solution to its franchise partners for setting up the health club. The franchise agreement entered ensures quality supervision of gym equipment, trainers, ambience etc. by TBVFL. Nu Form studio facilities would include: Weight Loss Muscular Strength and Endurance Enhanced Flexibility Back Pain Relief Nu Form studios opened in April 2012 received a great response with ~140 members in less than one month of its inauguration. Broaden its scope from being a gym player to a fitness player: Nu Form Gym Studios TBVFL being the market leader in the Indian Fitness Industry has broadened its scope from being a gym player to a fitness player by introducing Nu Form Gym studios with a focus on weight loss using the EMS (Electric Muscle Stimulation) method. Nu Form is priced at a significantly higher premium for people who are more conscious of weight loss than only of health and fitness in gyming. Currently 6 Nu Form Studios are operational in Mumbai (Andheri, Bandra, Chembur and Vile Parle) and Thane (Panch Pakhdi and Pokhran road Vasantvihar). Nu Form offered at a price point which is about 2.5 times a normal gym Talwalkars where TBVFL gets about Rs 15,000-18,000 p.a, in Nu Form it is charging between Rs ,000 p.a. So far Nu Form has got very good response and the company has also done some soft advertisements (on Bus stops) across Mumbai. The management has guided that though it will take some time to grow the membership in this format (the revenues may not grow significantly) but the margin improvement (higher product EBITDA) will be significant (expects the FY13E margins to be in-line with 4QFY12 margin). TBVFL has taken price increase in significant number of gyms in April 2012 which is post March results, so the management is expecting the resultant benefits to come in going forward. Consistent financial performance Number of Health Clubs has increased at a CAGR of 28% over FY07- FY13E. Number of Members has increased at a CAGR of 29% over FY07-FY13E. Achieved 4 year CAGR (FY 08-12) of 30% in Revenues, 35% in EBITDA & 44% in PAT. The company continues to maintain debt equity of ~ 1:1. The company has properties which has current market values considerably higher than the book value. MANAGEMENT GUIDANCE Confident of maintaining the revenue growth rate at 30-35% y-o-y. Margins will expand significantly in FY13E in line with 4QFY12 on account of high product EBIDTA Nu Form Studios. Talwalkars Better Value Fitness Ltd May-2012

6 CONCERNS Rising competition from local/global players basically on price front could be concern. VALUATIONS At the CMP of `159.50, the stock is trading at 10.9x its FY14E EPS of ` We recommend BUY on the stock with a months target price of `220, providing an upside of 38% from the current levels. Source: Company, Capitaline Registered Office: 124 Viraj, S,V.Road, Khar (W), Mumbai Tel. (022) , Fax (022) research@lmspl.com LMSPL Network: Fort, Mahalaxmi, Parel, Bandra, Santacruz, Vile Parle, Andheri, Malad, Kandivili, Borivali, Bhayender, Ghatkopar, Mulund, Chunabhatti, Jacob Circle, Masjid Bunder, Cotton Green, Thane, Bhiwandi, Panvel, Pune, Sholapur, Nasik, Malegoan, Ahmednagar, Aurangabad, Akola, Mahekar, Nagpur, Surat, Karjan(Baroda), Khambat, Ahmedabad, Rajkot, Surendranagar, Porbandar, Amreli, Bharuch, Anand, Chennai, Vishakhapatnam, Vizianagaram, Palasa, Kakinada, Karnal, Kolkatta, Bhubhaneshwar, Hyderabad, Bangalore, Jafrabad, Chital, Kodinar, Keshod, Gondal, Haryana, Srikakulam, Mehkar (Buldhana, Jamnagar, Bangalore, Jodhpur, Jalgaon, Malkangiri (Orissa), Karimnagar Dist. (Andhra Pradesh) This document is for information only and is meant for the use of the recipient & not for circulation. The information contained in this document has been taken from publicly available information, trade and statistical services & other sources. While the information contained herein is from sources believed to be reliable, we do not hold ourselves responsible for its completeness and accuracy. All opinions and estimates included in this report constitute our judgement as of this date and are subject to change without notice. Investors are expected to use the information contained in this report at their own risk. This report is not and should not be construed as an offer or the solicitation of an offer to buy or sell any securities. M/s Latin Manharlal Securities Pvt. Ltd. and its affiliates may act as market maker or have assumed an underwriting position in the secure-ties of companies discussed herein and may sell them to or buy them from customers on a principal basis. Talwalkars Better Value Fitness Ltd May-2012

NEW AGE FITNESS WITH VIRAT KOHLI

NEW AGE FITNESS WITH VIRAT KOHLI www.chisel.co.in TM NEW AGE FITNESS WITH VIRAT KOHLI A new paradigm in fitness, this state-of-the-art fitness centre promotes a very dynamic and diverse set of programs, that match the requirements of

More information

Thyrocare Wellness for your Wealth

Thyrocare Wellness for your Wealth A quality report by JainMatrix Investments Thyrocare Wellness for your Wealth Date 26 th April 2016 Price range: Rs. 420-446 and Period: 27-29 th April 2016 Advice: BUY with a 2 year perspective Mid Cap

More information

Consumer Wellness in India Growth Ahead

Consumer Wellness in India Growth Ahead 1 Consumer Wellness in India Growth Ahead Indian Health & Wellness industry Valued at over INR 590 bn, growing at CAGR of 18% - 20% p.a. Growth expected to continue. Industry growth being driven by: Increasing

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,

More information

FROST & SULLIVAN. Publications Division - Terms and Conditions of Business

FROST & SULLIVAN. Publications Division - Terms and Conditions of Business FROST & SULLIVAN Publications Division - Terms and Conditions of Business 1. Frost & Sullivan and FICCI takes no responsibility for any incorrect information supplied by manufacturers or users. Quantitative

More information

Insert Cover Image using Slide Master View Do not distort. Anti-Diabetic Pharmaceuticals Market - India

Insert Cover Image using Slide Master View Do not distort. Anti-Diabetic Pharmaceuticals Market - India Insert Cover Image using Slide Master View Do not distort Anti-Diabetic Pharmaceuticals Market - India March 2012 Eecutive Summar Market Drivers and Challenges Drug Regulation and Patents Global Market

More information

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce

More information

Singapore Exchange Limited 1Q FY2009 Financial Results

Singapore Exchange Limited 1Q FY2009 Financial Results Singapore Exchange Limited 1Q FY2009 Financial Results 15 October 2008 Singapore Exchange 1 1Q FY2009 Financial Performance NPAT fell 35% from record 1Q FY2008 Operating profit flat compared to 4Q FY2008

More information

Dabur India Ltd. BUY CMP (Rs.) 277 Target (Rs.) 344 Potential Upside 24% Investment Rationale. Volume No.. I Issue No. 40. September 8 th, 2015

Dabur India Ltd. BUY CMP (Rs.) 277 Target (Rs.) 344 Potential Upside 24% Investment Rationale. Volume No.. I Issue No. 40. September 8 th, 2015 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15. Volume No.. I Issue No. 40. Dabur India Ltd. September 8 th, 2015 BSE Code: 500096 NSE Code: DABUR Reuters Code:

More information

Dabur India Limited. October 10, CMP (Rs.) 284. Key Developments

Dabur India Limited. October 10, CMP (Rs.) 284. Key Developments Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 s. Dabur India Limited. October 10, 2016 BSE Code: 500096 NSE Code: DABUR Reuters Code: DABU.NS Bloomberg Code:

More information

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,

More information

CONSUMER BEHAVIOUR TOWARDS HOME FITNESS EQUIPMENT

CONSUMER BEHAVIOUR TOWARDS HOME FITNESS EQUIPMENT CONSUMER BEHAVIOUR TOWARDS HOME FITNESS EQUIPMENT Abstract Dr Seema Laddha 1 Fitness Equipment demand is one of the growing market in India due to awareness among the consumers, marketing strategies of

More information

Global Nutraceuticals Market

Global Nutraceuticals Market Published on NOVONOUS (https://www.novonous.com) Home > Global Nutraceuticals Market 2016-2020 Global Nutraceuticals Market 2016-2020 Publication ID: NOV1016004 Publication Date: October 14, 2016 Pages:

More information

Sub: PRESS RELEASE - Parag Milk Foods launches Avvatar Advanced Mass Gainer

Sub: PRESS RELEASE - Parag Milk Foods launches Avvatar Advanced Mass Gainer December 11, 2018 Compliance Department, BSE Limited, Phiroze Jeejeebhoy Tower, Dalal Street, Fort, Mumbai- 400001 Code No:- 539889 Compliance Department, National Stock Exchange of India Ltd. Exchange

More information

INSPIRE THE WORLD TO FITNESS

INSPIRE THE WORLD TO FITNESS INSPIRE THE WORLD TO FITNESS 2 0 0 9 M E D I A K I T Reaching one IDEA key influencer gets GAIAM in front of dozens of our target market health-minded consumers. This is also a great forum for seeing new

More information

The Emerging Trends in Indian Healthcare & the Role of Franchising

The Emerging Trends in Indian Healthcare & the Role of Franchising The Emerging Trends in Indian Healthcare & the Role of Franchising Preview India & Indian Healthcare Industry Key Facts Key Opportunities and Emerging Trends The Franchise Fit in healthcare industry The

More information

Myriad Genetics Corporate Presentation 06/13/2018

Myriad Genetics Corporate Presentation 06/13/2018 Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. Brazil Nutraceuticals Industry Introduction 1.1. Government Rules and Regulations 2. Brazil Nutraceuticals Industry Size by Revenues, 2006-2012 3. Brazil Nutraceuticals Market Segmentation

More information

Investor Relations 1Q 2017

Investor Relations 1Q 2017 Investor Relations 1Q 2017 History Leading Authentic Sports Brand Inspired by the Style, Elegance and Passion of our Italian Heritage Founded by FILA brothers in Biella, Italy Established FILA Korea FILA

More information

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Coloplast has four business areas all with global sales presence Group revenue

More information

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

An exciting combination in a high growth, high margin Nutrition category. Name of chairman An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views

More information

A GLOBAL LEADER IN PERSONALIZED NUTRITION

A GLOBAL LEADER IN PERSONALIZED NUTRITION A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking

More information

Investor Update May 2016

Investor Update May 2016 Investor Update May 2016 Novo Nordisk poised for growth through helping care for rising global diabetes epidemic On Marsico Capital Management s trip to Australia in March, Portfolio Managers Tom Marsico

More information

QUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010

QUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010 QUALITAS MEDICAL GROUP LIMITED CORPORATE PRESENTATION January 2010 Contents Our Business Corporate Developments Growth Strategies Financial Highlights Summary Business Overview Who We Are Established in

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market

More information

Sirtex Medical Ltd Buy

Sirtex Medical Ltd Buy Research Sirtex Medical Ltd Buy Price: A$16.32 Price Target: A$20.50 ASX: SRX 21 April 2017 Sirtex Medical (SRX) is a global medical device company which targets cancer therapies, with its lead product

More information

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014 1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include

More information

Small-Cap Research. Celator Pharma (CPXX-NASDAQ)

Small-Cap Research. Celator Pharma (CPXX-NASDAQ) Small-Cap Research June 24, 2015 Grant Zeng, CFA 312-265-9466 gzeng@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Celator Pharma (CPXX-NASDAQ) CPXX: Positive top line data reported for

More information

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE Occasion: Initial coverage +37% +71% 100% one-week return? s share price has dropped by more than 50% since the announcement of the current and ongoing public offering. In theory the share price should

More information

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

Walgreens (WAG) Analyst: Juan Fabres Fall 2014 Recommendation: Buy Target Price August 31, 2016: $77.57 1. Reasons for the Recommendation With the acquisition of Alliance Boots in Europe, Walgreens will be the first US pharmacy to operate retail stores

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

Putting ALK on the right growth trajectory

Putting ALK on the right growth trajectory Putting ALK on the right growth trajectory Økonomisk Ugebrevs Kapitalmarkedseftermiddag 15. marts 2018 Per Plotnikof, VP Corporate Communications and IR Marts 2018 Allergy: a global disease with a large

More information

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( )

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( ) Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,

More information

Malaysian Palm Oil Prospects & Opportunities in Pakistan. By Fatimah Zaharah Md Nan Faisal Iqbal Malaysian Palm Oil Council

Malaysian Palm Oil Prospects & Opportunities in Pakistan. By Fatimah Zaharah Md Nan Faisal Iqbal Malaysian Palm Oil Council Malaysian Palm Oil Prospects & Opportunities in Pakistan By Fatimah Zaharah Md Nan Faisal Iqbal Malaysian Palm Oil Council Outline Pakistan Agriculture Sector Domestic Oils and Fats Scenario Palm Oil Trade

More information

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations Company Update Industrial & Consumer Technology 22nd Century Group, Inc. (XXII - $2.21 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com

More information

Natus Medical Incorporated. Jeffries Global Healthcare CONFERENCE Tuesday June 6, 2017

Natus Medical Incorporated. Jeffries Global Healthcare CONFERENCE Tuesday June 6, 2017 Natus Medical Incorporated Jeffries Global Healthcare CONFERENCE Tuesday June 6, 2017 Forward-Looking Statements This presentation contains forward-looking statements including statements regarding our

More information

For personal use only

For personal use only ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting

More information

Strategic Plan

Strategic Plan Strategic Plan 2013-2016 Bringing Fitness, Fun & Friendship to University life. Tel (08) 8313 6999 Level 5, Union House, Victoria Drive University of Adelaide SA 5005 www.thefitnesshub.com.au Table of

More information

Universal Biosensors, Inc.

Universal Biosensors, Inc. Universal Biosensors, Inc. ARBN 121 559 993 Buchan Three Tickers Presentation 18 th September 2013 1 Important Disclaimer This presentation is intended to provide a general outline only and is not intended

More information

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p

More information

Introductory Presentation

Introductory Presentation Introductory Presentation WEEK 6 WEEK WEEK 1 2 WEEK 5 WEEK 3-4 STRUCTURED HORIZON WELCOME TO THE FAMILY FRANCHISE AGREEMENT DELIVERY PERSONALIZED FRANCHISE AGREEMENTS DELIVERED DAY OF DISCOVERY MEET THE

More information

Q Investor Kit JANUARY-MARCH 2014

Q Investor Kit JANUARY-MARCH 2014 Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

MDxHealth. Excellent Buy Opportunity. Research Note.

MDxHealth. Excellent Buy Opportunity. Research Note. Research Note MDxHealth Excellent Buy Opportunity Chief Research Analyst Marcel Wijma MSc +1 (917) 460 6185 (US) +31 (6) 8489 2954 (NL) m.wijma@leeuwenhoeck.com http://www.leeuwenhoeck.com Date: 29 February

More information

FRANCHISE INFORMATION REPORT

FRANCHISE INFORMATION REPORT FRANCHISE INFORMATION REPORT Tapout is one of the most widely recognized lifestyle brands and is the official fitness and training partner of WWE. We are striving to take that brand recognition one step

More information

A world leader in allergy immunotherapy

A world leader in allergy immunotherapy A world leader in allergy immunotherapy Investor Relations presentation June 2017 1 I Investor Relations presentation I June 2017 ALK: Towards redefining treatment of severe allergies The commercial leader

More information

Corcept Therapeutics, Inc.

Corcept Therapeutics, Inc. March 20, 2015 Corcept Therapeutics, Inc. NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 03/20/2015 Current Price (03/19/15) $5.85 Target Price $6.25 (CORT-NASDAQ) SUMMARY

More information

Financial Presentation

Financial Presentation Financial Presentation Certain of the statements that will be made during this meeting, as well as statements contained in our 2006 Annual Report to Shareholders and Annual Report on Form 10-K filed with

More information

22nd Century Group, Inc. (XXII - $ Buy)

22nd Century Group, Inc. (XXII - $ Buy) Company Update Industrial & Consumer Technology 22nd Century Group, Inc. (XXII - $2.47 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com

More information

GLOBAL INSIGHT SERIES. Global Baking Insights: Gluten-Free Bread Consumption

GLOBAL INSIGHT SERIES. Global Baking Insights: Gluten-Free Bread Consumption Global Baking Insights: Gluten-Free Bread Consumption Gluten-Free bread is moving mainstream, creating huge innovation opportunities for bakeries The baking industry has experienced significant change

More information

The Dental Corporation Opportunity

The Dental Corporation Opportunity The Dental Corporation Opportunity for Practice Principals. It s the perfect professional collaboration. You focus on dentistry, we look after the paperwork. In recognition of what you, the Practice Principal,

More information

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers

More information

Shareholder Presentation Annual Meeting 2018

Shareholder Presentation Annual Meeting 2018 Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)

More information

Healthcare for the Emerging Middle Class

Healthcare for the Emerging Middle Class Healthcare for the Emerging Middle Class Type 2 diabetes care design in India May 2014 1 When looking for healthcare opportunities in emerging markets, project teams on the ground are less influenced by

More information

DS-8201 Strategic Collaboration

DS-8201 Strategic Collaboration DS-8201 Strategic Collaboration DAIICHI SANKYO CO., LTD George Nakayama Chairman and CEO March 29, 2019 Forward-Looking Statements Management strategies and plans, financial forecasts, future projections

More information

Social Franchising as a Strategy for Expanding Access to Reproductive Health Services

Social Franchising as a Strategy for Expanding Access to Reproductive Health Services Social Franchising as a Strategy for Expanding Access to Reproductive Health Services A case study of the Green Star Service Delivery Network in Pakistan Background Pakistan has a population of 162 million

More information

DelMar Pharmaceuticals Inc. (OTCQX: DMPI, Target Price: $5.75)

DelMar Pharmaceuticals Inc. (OTCQX: DMPI, Target Price: $5.75) Equity Healthcare / Biotechnology Update (December 3, 2015) DelMar Pharmaceuticals Inc. (OTCQX: DMPI, Target Price: $5.75) DelMar Pharmaceuticals, Inc. ( DelMar, OTCQX: DMPI) is a clinical stage biotechnology

More information

BODYTECH FITNESS FRANCHISE OPPORTUNITY

BODYTECH FITNESS FRANCHISE OPPORTUNITY BODYTECH FITNESS FRANCHISE OPPORTUNITY THE BODYTECH STORY Bodytech Fitness Australia established In 2013, by owner Daniel Slaveski, a respected authority on fitness and personal training who followed his

More information

FIRSTQUARTER2018 RESULTSPRESENTATION

FIRSTQUARTER2018 RESULTSPRESENTATION FIRSTQUARTER2018 RESULTSPRESENTATION May 14 th 2018 Juan Lladó CEO 1 DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection

More information

2015 Investor Conference

2015 Investor Conference 2015 Investor Conference ACCELERATING PROFITABLE GROWTH Jill Schaaf President, Renal Care Teeramanas Tanaekakarapong, ESRD Patient, Bangkok, Thailand Becoming The Global Leader In Renal Care Our Global

More information

Investment in MGC Pharmaceuticals

Investment in MGC Pharmaceuticals Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information

More information

Companies Database, Mobile Database, Id Database, Credit

Companies Database, Mobile Database,  Id Database, Credit m All India Database We Provides Database Companies Database, Mobile Database, Email Id Database, Credit Card Holder Database, Corporate database, CEO s Database, Corporate Employee Database, Car s Owner

More information

Enel Américas 1Q 2018 results

Enel Américas 1Q 2018 results Enel Américas 1Q 2018 results 1Q 2018 results Highlights of the period EBITDA of 820 musd, an increase of 26% vs 1Q 2017 Generation EBITDA increased by 17% due to better prices in Argentina and consolidation

More information

A NEW Market Combining Fitness, Alternative Health and Beauty

A NEW Market Combining Fitness, Alternative Health and Beauty A NEW Market Combining Fitness, Alternative Health and Beauty Fast Facts Founded 2011 Incorporated Denver, CO Address 10841 S. Crossroads Dr. Suite 209 Parker, CO 80134 Locations 1 FABstudio (COMPANY OWNED)

More information

FY2016 1H Results. Cookpad Inc.

FY2016 1H Results. Cookpad Inc. FY2016 1H Results Cookpad Inc. 1 1H Highlights Premium Service -Premium Service revenue increased by 39.6% YoY. -Number of premium members grew by 12.0% YoY to exceed 1.85 million. Advertising -Advertising

More information

January 30, 2018 Dow Wilson President and Chief Executive Officer

January 30, 2018 Dow Wilson President and Chief Executive Officer Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking

More information

Colgate Palmolive India Limited Slide 1

Colgate Palmolive India Limited Slide 1 Colgate Palmolive India Limited Slide 1 Colgate Palmolive India Ltd Colgate Palmolive India Limited Slide 2.since 1937 Disclaimer This Presentation and its related publication, release, webcast or communication

More information

Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595

Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595 Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample

More information

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK Small-Cap Research November 16, 2017 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final

More information

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK Small-Cap Research February 2, 2016 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Ste 1600, Chicago, IL 60606 VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive

More information

The US Meal Kit Market: Size, Trends & Forecasts ( ) August 2017

The US Meal Kit Market: Size, Trends & Forecasts ( ) August 2017 The US Meal Kit Market: Size, Trends & Forecasts (2017-2021) August 2017 The US Meal Kit Market Report Scope of the Report The report entitled The US Meal Kit Market: Size, Trends & Forecasts (2017-2021),

More information

VITROLIFE AB (PUBL) Pareto Securities Health Care Conference

VITROLIFE AB (PUBL) Pareto Securities Health Care Conference VITROLIFE AB (PUBL) Pareto Securities Health Care Conference 2018-09-06 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION

More information

Start your own diet and weight loss business! FabJob Guide to. Become a. Weight Loss. Center Owner. Pamela White. Visit

Start your own diet and weight loss business! FabJob Guide to. Become a. Weight Loss. Center Owner. Pamela White. Visit Start your own diet and weight loss business! FabJob Guide to Become a Weight Loss Center Owner Pamela White Visit www.fabjob.com Contents About the Author...9 Acknowledgements...9 1. Introduction...10

More information

ASX Investor Presentation

ASX Investor Presentation ASX Investor Presentation Sydney, Australia Dr Peter Neustadt Executive Chairman and CEO November 2014 Copyright and registered trademark notice ASX Investor Presentation Page 0 Who we are SomnoMed Limited

More information

FITNESS EQUIPMENT & GYM DESIGN

FITNESS EQUIPMENT & GYM DESIGN FITNESS EQUIPMENT & GYM DESIGN Origin Fitness specialises in providing the best in fitness equipment along with an expertise in gym design, installation and customer service. UK based, with over a decade

More information

RUBBER GLOVES. Rationale for report : Sector update

RUBBER GLOVES. Rationale for report : Sector update Investment Highlights RUBBER GLOVES RUBBER PRODUCTS Ebola - the latest health scare 5 August 2014 NEUTRAL Cheryl Tan cheryl-tan@ambankgroup.com +603 2036 2333 Rationale for report : Sector update (Maintained)

More information

GLOBAL NEUROSTIMULATION MARKET

GLOBAL NEUROSTIMULATION MARKET GLOBAL NEUROSTIMULATION MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d

More information

MDxHealth. Strong outlook for Research Note.

MDxHealth. Strong outlook for Research Note. Research Note MDxHealth Strong outlook for 2017 Chief Research Analyst Marcel Wijma MSc +1 (917) 460 6185 (US) +31 (6) 8489 2954 (NL) m.wijma@leeuwenhoeck.com http://www.leeuwenhoeck.com Date: 23 February

More information

Global Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022

Global Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022 Global Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022 By Value (In Million USD) By Volume (In Million Units)

More information

Growth of s 1 lac invested on inception date. SIP Performance: Scheme Name 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr. CNX Midcap

Growth of s 1 lac invested on inception date. SIP Performance: Scheme Name 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr. CNX Midcap BNP Paribas Midcap The investment objective of the is to seek to generate long-term capital appreciation by investing primarily in companies with high growth opportunities in the middle and small capitalization

More information

ELICA 2012 Q3 RESULTS. November 14,

ELICA 2012 Q3 RESULTS. November 14, ELICA ELICA 1 Q3 12 Highligths Negative market demand, showing better trend compared to previous quarters Group sales over performing in all major markets Cost reduction efforts and continued product innovation

More information

Global Epilepsy Market: Industry Analysis & Outlook

Global Epilepsy Market: Industry Analysis & Outlook Industry Research by Koncept Analytics Global Epilepsy Market: Industry Analysis & Outlook ----------------------------------------- February 2017 1 Executive Summary Epilepsy is a group of neurological

More information

artnet AG Quarterly Interim Statement for the First Quarter of 2017 artnet AG Quarterly Interim Statement for the First Quarter of 2017

artnet AG Quarterly Interim Statement for the First Quarter of 2017 artnet AG Quarterly Interim Statement for the First Quarter of 2017 Quarterly Interim Statement for the First Quarter of 2017 Quarterly Interim Statement for the First Quarter of 2017 Table of Contents General Information and Business Activities Economic Development of

More information

Itamar Medical. December Investors Presentation.

Itamar Medical. December Investors Presentation. Itamar Medical December 2017. Investors Presentation. Disclaimer Itamar Medical Ltd. (the "Company") is furnishing this presentation and any information given during this presentation, solely for the consideration

More information

Systematic Investment Plan Report

Systematic Investment Plan Report s ICICI Prudential Focused Bluechip Equity Fund - Ret - Growth SBI Bluechip Fund - Growth Nifty 50 S&P BSE 100 3 Yr 180000 201294 723 184833 169 3 Yr 180000 207838 934 187449 259 5 Yr 300000 410356 1232

More information

Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts

Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts NuSep (ASX:NSP) key facts No. shares 237,606,002 Market Cap. $7.1 million (@3 cps) No. of shareholders Approx.

More information

1Q 2009 Results Presentation. 12 May 2009

1Q 2009 Results Presentation. 12 May 2009 1Q 2009 Results Presentation 12 May 2009 1 Broadcasting 2 MEDIASET 2009 1Q Total Audience TOTAL AUDIENCE (Jan-Mar) * Individuals Δ vs. 2008 +5.3% 15-64 years +5.6% 1Q TV CONSUMPTION (2000-2009) Average

More information

Q Investor Kit JANUARY-MARCH 2013

Q Investor Kit JANUARY-MARCH 2013 Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

A world leader in allergy immunotherapy

A world leader in allergy immunotherapy A world leader in allergy immunotherapy Company presentation Per Plotnikof, VP Corporate Communications and IR 1 I ALK at a glance Commercial leader and foremost innovator within respiratory allergies

More information

YOUR FRANCHISE OPPORTUNITIES AWAIT. OTFfranchise.ca

YOUR FRANCHISE OPPORTUNITIES AWAIT. OTFfranchise.ca YOUR FRANCHISE OPPORTUNITIES AWAIT. OTFfranchise.ca is more than a workout. It is not the next fitness fad. It is a lifestyle. People don t just become healthier here, they come home here. They change

More information

Q Investor Kit JANUARY-JUNE 2014

Q Investor Kit JANUARY-JUNE 2014 Q2 2014 Investor Kit JANUARY-JUNE 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

Small-Cap Research. Delmar Pharma (DMPI-OTCQB)

Small-Cap Research. Delmar Pharma (DMPI-OTCQB) Small-Cap Research February 24, 2015 Grant Zeng, CFA 312-265-9466 gzeng@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Delmar Pharma (DMPI-OTCQB) DMPI: Ready to advance VAL-083 to pivotal

More information

Altria Group Inc (MO-NYSE)

Altria Group Inc (MO-NYSE) March 20, 2015 Altria Group Inc (MO-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 08/12/2009 Current Price (03/19/15) $51.27 Target Price $54.00

More information

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( ) Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications

More information

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 for Table of Contents General Information and Business Activities Economic Development

More information

Russia Cardiac Assist Devices Market Outlook to 2021

Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected publishers for

More information

Genomic Health. Kim Popovits, Chairman, CEO and President

Genomic Health. Kim Popovits, Chairman, CEO and President Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and

More information

QUICKER ABACUS ACADEMY

QUICKER ABACUS ACADEMY QUICKER ABACUS ACADEMY REG NO. 41081302519 #94, Saheed Nagar, Bhubaneswar, Odisha Email: quickerabacus@gmail.com www.quickerabacus.com Nurturing the Minds BUSINESS PLAN 1 Nurturing the Minds ABOUT QUICKER

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We

More information

GYM EQUIPMENT SPECIALISTS

GYM EQUIPMENT SPECIALISTS GYMSTORE GYM EQUIPMENT SPECIALISTS ABOUT US G Y M E Q U I P M E N T S P E C I A L I S T S THE WORLD IS ALWAYS CHANGING ALL AROUND US WITH PEOPLE LIVING BUSIER AND MORE STRESSFUL LIFESTYLES. TO CONTINUE

More information

Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc. February 27, 2015 Orexigen Therapeutics, Inc. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 06/06/2012 Current Price (02/26/15) $5.87 Target Price $6.25 SUMMARY DATA

More information